Requests similar to 'Pfizer Covid-19 Vaccine study pre-print unpublished 2' (page 5)
Covid-19 Virus Risk of Myocarditis greather than Risk of Myocarditis from Vaccine
Response by Ministry of Health to Chris McCashin on .
Awaiting classification.
Kia ora Chris,
Thank you for your request for official information to the Manatū Hauora
Ministry of Health (the Ministry), on 8 August 2022...
Deaths and Miscarriage adverse reactions following Covid-19 vaccination
Request sent to Ministry of Health by Mary Devlin on .
Successful.
Information about adverse reactions to the COVID-19 vaccine is currently included in the weekly updates about COVID-19 vaccine data issued by the Mi...
Pfizer Vaccinations
Response by Ministry of Health to Chuck Schooner (Account suspended) on .
Awaiting classification.
Kia ora Chuck
Please find attached a response to your request for official information.
Ngā mihi
OIA Services Team
[1]Ministry of Healt...
Determination of SARSCoV-2 vaccine BNT162b2 (COMIRNATY)
Request sent to Environmental Protection Authority by Maxwell on .
Successful.
I write as a New Zealand citizen.
In your application decision made 11 February 2021 (APP204176) "To determine under section 26 of the Hazardous S...
Studies showing that the Comirnaty/Pfizer-BioNTech 'vaccine' is 'safe and effective'
Response by Ministry of Health to Debbie on .
Awaiting classification.
Kia ora Debbie,
Please see attached the response to your OIA request.
Ngā mihi
OIA Services Team...
Results of the Pfizer vaccine safety and immunogenicity in pregnant women
Request sent to Ministry of Health by Erika Whittome on .
Long overdue.
This study C4591015 on pregnant women is listed in the Medsafe Risk Management Report https://www.medsafe.govt.nz/COVID-19/Comirnaty-RMP.pdf
"To...
2 March 2021 Vaccination advice, BORA and medicine approval/safety/quality
Response by Public Service Commission to Erika Whittome on .
Partially successful.
Kia ora Erika
Please find attached our response to your request for official information
below.
Ngā mihi
Enquiries Team
īmēra: [1]...
Reviews on the FDA report on vaccines 22 Oct 2020
Response by Ministry of Health to Erika Whittome on .
Information not held.
Kia ora,
Please find attached the response for your request for official
information.
Ngā mihi,
OIA Services Team
Ministry of Health | Manat...
Kia ora Dennis,
Thank you for your email. Weekly reports summarising the number and type
of adverse events following immunisation (AEFI) re...
The results of the Pfizer vaccine study on ages 12 years and under
Request sent to Ministry of Health by Erika Whittome on .
Long overdue.
The Medsafe Risk Management Plan lists this study C4591007 as one of the additional pharmacovigilance activities.
The study C4591007 is "To asse...
DNA plasmids and SV40 in mRNA covid 19 vaccines
Response by Ministry of Health to nikita mahendra on .
Refused.
Kia ora Nikita
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry o...
Disclosure of SV40 promoter in pfizer injectables to medsafe/MOH
Response by Ministry of Health to R. Kingi on .
Refused.
Kia ora R
Please find attached the response to your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauo...
Kia ora Erika
Please find attached a letter regarding your request for official
information. If you wish to discuss any aspe...
Kia ora Alison,
Thank you for your request for information on 21/04/2026. Please find
attached our response to your request.
If you have any...
Copy of information about the PCR test for Covid
Response by Chris Hipkins to Debra Gillespie on .
Awaiting classification.
Tēnā koe Debra
Thank you for your request under the Official Information Act 1982 (the
Act), transferred to the Ministry of Health (the Ministr...
In Australia, the following was released in foi-2389-06.pdf
Nonclinical Evaluation Report
BNT162b2 [mRNA] COVID-19 vaccine
(COMIRNATYTM)
Submissio...
Risks Outweigh Benefits to Children
Long overdue.
"Do people know that the pfizer/biontech and comirnaty are actually two vaccines"
Did you actually read the link you provided?
Quote: "COMIRNATY (C...
Comirnaty (COVID-19 mRNA vaccine) with active ingredient BNT162b2
Request sent to Ministry of Health by Heather Darby on .
Refused.
Please provide any and all information that has been provided to the Ministry of Health or Medsafe pertaining to the product Comirnaty (COVID-19 mRN...
What are all the usual safety checks and regulations for the pfizer covid medicine?
Request sent to Ministry of Health by Erika Whittome on .
Long overdue.
I refer to your webpage from 2021 which says:
"mRNA vaccines have been in development for decades
mRNA vaccines have been developed through major...
Annotation: Global Shadows of Secrecy: FOI/FOIA Struggles for Pfizer & Moderna Vaccine Efficacy and Safety Data
This New Zealand OIA (ref: H202507366...
What are the particular clinical trials referred to here: https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/cov...
Covid 19 Vaccinations - Health NZ Potential Side Effect Warnings vs Side Effects Reported to CARM
Awaiting classification.
Annotation: Transparency in COVID-19 Vaccine Warnings and Adverse Event Reporting – Insights from OIA Request #32014
For New Zealanders Following Vac...
Risk Assessments and PPE Standards for Pfizer Vaccine Handling in New Zealand
Response by Ministry of Health to John Armstrong on .
Partially successful.
Dear John,
I refer to your request for the following information, as transferred to
the University of Auckland on 1 May 2026 from HNZ:
"4. Train...
Official Information Act Request Regarding Excess Deaths and COVID-19 Vaccination in New Zealand
Response by Statistics New Zealand to Lance D. Lavery on .
Partially successful.
Kia ora Lance,
Please see the attached response to your request for official information.
Ngā mihi
OIA Services Team
Manatū Hauora | Minis...
Pfizer Bivalent Vaccine - Avaialability
Response by Ministry of Health to Garry Venus on .
Successful.
Tēnā koe Garry,
Thank you for your request under the Official Information Act 1982 (the
Act) on 18 September 2022. You asked:
“(1) Plea...